Researchers developed BioCompNet, a dual-sequence AI system that automates body composition measurement from MRI scans for improved cardiometabolic risk management.
Key Details
- 1BioCompNet uses a dual-channel 2D U-Net framework to process fat- and water-sequence MRI for abdominal and thigh segmentation.
- 2It quantifies 15 key body composition components automatically, including muscle, bone, and various fat compartments.
- 3Tested on 503 subjects internally and 30 cases externally, it achieved mean Dice scores of 0.938 (abdomen) and 0.936 (thigh) with strong physician agreement (ICC 0.881–0.999).
- 4Automated processing takes 0.12 minutes per case, compared to 128.8 minutes manually, enabling large-scale studies.
- 5Limitations include the need for broader validation across populations, refinement of clinical integration, and multicenter studies for further generalizability.
Why It Matters
This workflow represents a significant advance in scalable, automated MRI quantitative analysis, potentially enabling precise risk assessment and management for cardiometabolic diseases. It reduces the labor required for body composition measurements, supporting both large-cohort research and future clinical deployment.
Source
EurekAlert
Related News
•EurekAlert
AI Model Improves Differentiation of Brain Tumor Progression from Radiation Necrosis on MRI
A York University-led study shows a novel AI using advanced MRI can distinguish between progressive brain tumors and radiation necrosis more accurately than human assessment.
•EurekAlert
AutoML Model Accurately Differentiates Brain Tumors on MRI
Thomas Jefferson University researchers developed an AutoML model that distinguishes pituitary macroadenomas from parasellar meningiomas on MRI with over 97% accuracy.
•EurekAlert
Survey: Public Trusts Doctors Over AI, But Embraces AI For Cancer Diagnosis
Most people trust doctors more than AI for health diagnoses, but see significant potential for AI tools in cancer detection.